Identification of protein binding partners of small molecules using label-free methods

References

• Swinney DC, Anthony J. How were new medicines discovered? Nat Rev Drug Discov. 2011;10:507–519. doi:10.1038/nrd3480.
   PubMed Web of Science ®Google Scholar
• Eder J, Sedrani R, Wiesmann C. The discovery of first-in-class drugs: origins and evolution. Nat Rev Drug Discov. 2014;13:577–587. doi:10.1038/nrd4336.
   PubMed Web of Science ®Google Scholar
• Wagner BK, Schreiber SL. The power of sophisticated phenotypic screening and modern mechanism-of-action methods. Cell Chem Biol. 2016;23:3–9. doi:10.1016/j.chembiol.2015.11.008.
   PubMed Web of Science ®Google Scholar
• Lee JA, Berg EL. Neoclassic drug discovery: the case for lead generation using phenotypic and functional approaches. J Biomol Screen. 2013;18:1143–1155. doi:10.1177/1087057113506118.
   PubMed Web of Science ®Google Scholar
• Schirle M, Jenkins JL. Identifying compound efficacy targets in phenotypic drug discovery. Drug Discov Today. 2016;21:82–89. doi:10.1016/j.drudis.2015.08.001.
   PubMed Web of Science ®Google Scholar
• Dawson JC, Carragher NO. Quantitative phenotypic and pathway profiling guides rational drug combination strategies. Front Pharmacol. 2014;5:118. doi:10.3389/fphar.2014.00118.
   PubMed Web of Science ®Google Scholar
• Moffat JG, Rudolph J, Bailey D. Phenotypic screening in cancer drug discovery – past, present and future. Nat Rev Drug Discov. 2014;13:588–602. doi:10.1038/nrd4366.
   PubMed Web of Science ®Google Scholar
• Prior M, Chiruta C, Currais A, et al. Back to the future with phenotypic screening. ACS Chem Neurosci. 2014;5:503–513. doi:10.1021/cn500051h.
   PubMed Web of Science ®Google Scholar
• Gilbert IH. Drug discovery for neglected diseases: molecular target-based and phenotypic approaches. J Med Chem. 2013;56:7719–7726. doi:10.1021/jm400362b.
   PubMed Web of Science ®Google Scholar
• Patel AC. Clinical relevance of target identity and biology: implications for drug discovery and development. J Biomol Screen. 2013;18:1164–1185. doi:10.1177/1087057113505906.
   PubMed Web of Science ®Google Scholar
• Saxena C, Zhen E, Higgs RE, et al. An immuno-chemo-proteomics method for drug target deconvolution. J Proteome Res. 2008;7:3490–3497. doi:10.1021/pr800222q.
   PubMed Web of Science ®Google Scholar
• Saxena C, Higgs RE, Zhen E, et al. Small-molecule affinity chromatography coupled mass spectrometry for drug target deconvolution. Expert Opin Drug Discov. 2009;4:701–714. doi:10.1517/17460440903005565
   PubMed Web of Science ®Google Scholar
• Terstappen GC, Schlüpen C, Raggiaschi R, et al. Target deconvolution strategies in drug discovery. Nat Rev Drug Discov. 2007;6:891–903. doi:10.1038/nrd2410.
   PubMed Web of Science ®Google Scholar
• Heynen-Genel S, Pache L, Chanda SK, et al. Functional genomic and high-content screening for target discovery and deconvolution. Expert Opin Drug Discov. 2012;7:955–968. doi:10.1517/17460441.2012.711311.
   PubMed Web of Science ®Google Scholar
• Lee J, Bogyo M. Target deconvolution techniques in modern phenotypic profiling. Curr Opin Chem Biol. 2013;17:118–126. doi:10.1016/j.cbpa.2012.12.022.
   PubMed Web of Science ®Google Scholar
• Wang J, Gao L, Lee YM, et al. Target identification of natural and traditional medicines with quantitative chemical proteomics approaches. Pharmacol Ther. 2016;162:10–22. doi:10.1016/j.pharmthera.2016.01.010.
   PubMed Web of Science ®Google Scholar
• Bantscheff M, Drewes G. Chemoproteomic approaches to drug target identification and drug profiling. Bioorg Med Chem. 2012;20:1973–1978. doi:10.1016/j.bmc.2011.11.003.
   PubMed Web of Science ®Google Scholar
• Wright MH, Sieber SA. Chemical proteomics approaches for identifying the cellular targets of natural products. Nat Prod Rep. 2016;33:681–708. doi:10.1039/c6np00001k.
   PubMed Web of Science ®Google Scholar
• Bantscheff M. Mass spectrometry-based chemoproteomic approaches. Methods Mol Biol. 2012;803:3–13. doi:10.1007/978-1-61779-364-6_1.
   PubMedGoogle Scholar
• Chang J, Kim Y, Kwon HJ. Advances in identification and validation of protein targets of natural products without chemical modification. Nat Prod Rep. 2016;33:719–730. doi:10.1039/c5np00107b.
   PubMed Web of Science ®Google Scholar
• Saxena C, Bonacci TM, Huss KL, et al. Capture of drug targets from live cells using a multipurpose immuno-chemo-proteomics tool. J Proteome Res. 2009;8:3951–3957. doi:10.1021/pr900277x.
   PubMed Web of Science ®Google Scholar
• Target ID Services. Shantani. [ cited 2016 Aug 12]. Available from: http://www.shantani.com/Services%20Products.php.
   Google Scholar
• Smith GP. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science. 1985;228:1315–1317. doi:10.1126/science.4001944.
   PubMed Web of Science ®Google Scholar
• Rossenu S, Dewitte D, Vandekerckhove J, et al. A phage display technique for a fast, sensitive, and systematic investigation of protein–protein interactions. J Protein Chem. 1997;16:499–503. doi:10.1023/A:1026317612554.
   PubMedGoogle Scholar
• Shim JS, Lee J, Park HJ, et al. A new curcumin derivative, HBC, interferes with the cell cycle progression of colon cancer cells via antagonization of the Ca2 + /calmodulin function. Chem Biol. 2004;11:1455–1463. doi:10.1016/j.chembiol.2004.08.015.
   PubMed Web of Science ®Google Scholar
• Licitra EJ. Liu JO. A three-hybrid system for detecting small ligand–protein receptor interactions. Proc Natl Acad Sci USA. 1996;93:12817–12821. doi:10.1073/pnas.93.23.12817.
   PubMed Web of Science ®Google Scholar
• Gray NS, Wodicka L, Thunnissen AMWH, et al. Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors. Science. 1998;281:533–538. doi:10.1126/science.281.5376.533.
   PubMed Web of Science ®Google Scholar
• Zhu H, Snyder M. Protein chip technology. Curr Opin Chem Biol. 2003;7:55–63.
   PubMed Web of Science ®Google Scholar
• Jacinto E, Hall MN. Tor signalling in bugs, brain and brawn. Nature Rev Mol Cell Biol. 2003;4:117–126. doi:10.1038/nrm1018.
   PubMed Web of Science ®Google Scholar
• Huang J, Zhu H, Haggarty SJ, et al. Finding new components of the target of rapamycin (TOR) signaling network through chemical genetics and proteome chips. Proc Natl Acad Sci USA. 2004;101:16594–16599. doi:10.1073/pnas.0407117101.
   PubMed Web of Science ®Google Scholar
• Godl K, Wissing J, Kurtenbach A, et al. An efficient proteomics method to identify the cellular targets of protein kinase inhibitors. Proc Natl Acad Sci U S A. 2003;100:15434–15439. doi:10.1073/pnas.2535024100.
   PubMed Web of Science ®Google Scholar
• Brehmer D, Greff Z, Godl K, et al. Cellular targets of gefitinib. Cancer Res. 2005;65:379–382.
   PubMed Web of Science ®Google Scholar
• Bantscheff M, Eberhard D, Abraham Y, et al. Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors. Nat Biotechnol. 2007;25:1035–1044. doi:10.1038/nbt1328
   PubMed Web of Science ®Google Scholar
• Ong SE, Schenone M, Margolin AA, et al. Identifying the proteins to which small-molecule probes and drugs bind in cells. Proc Natl Acad Sci USA. 2009;106:4617–4622. doi:10.1073/pnas.0900191106.
   PubMed Web of Science ®Google Scholar
• Zhu S, Wurdak H, Wang J, et al. A small molecule primes embryonic stem cells for differentiation. Cell Stem Cell. 2009;4:416–426. doi:10.1016/j.stem.2009.04.001.
   PubMed Web of Science ®Google Scholar
• Trippier PC, Zhao KT, Fox SG, et al. Proteasome activation is a mechanism for pyrazolone small molecules displaying therapeutic potential in amyotrophic lateral sclerosis. ACS Chem Neurosci. 2014;5:823–829. doi:10.1021/cn500147v.
   PubMed Web of Science ®Google Scholar
• Smith E, Collins I. Photoaffinity labeling in target- and binding-site identification. Future Med Chem. 2015;7:159–183. doi:10.4155/fmc.14.152.
   PubMed Web of Science ®Google Scholar
• Fleming SA. Chemical reagents in photoaffinity labeling. Tetrahedron. 1995;51:12479–12520. doi:10.1016/0040-4020(95)00598-3.
   Web of Science ®Google Scholar
• Webb Y, Zhou X, Ngo L, et al. Photoaffinity labeling and mass spectrometry identify ribosomal protein S3 as a potential target for hybrid polar cytodifferentiation agents. J Biol Chem. 1999;274:14280–14287. doi:10.1074/jbc.274.20.14280.
   PubMed Web of Science ®Google Scholar
• Kotake Y, Sagane K, Owa T, et al. Splicing factor SF3b as a target of the antitumor natural product pladienolide. Nat Chem Biol. 2007;3:570–575. doi:10.1038/nchembio.2007.16.
   PubMed Web of Science ®Google Scholar
• Zhang L, Zhang Y, Dong J, et al. Design and synthesis of novel photoaffinity probes for study of the target proteins of oleanolic acid. Bioorg Med Chem Lett. 2012;22:1036–1039. doi:10.1016/j.bmcl.2011.11.123.
   PubMed Web of Science ®Google Scholar
• Colca JR, McDonald WG, Cavey GS, et al. Identification of a mitochondrial target of thiazolidinedione insulin sensitizers (mTOT) – relationship to newly identified mitochondrial pyruvate carrier proteins. PLoS ONE. 2013;8:e61551. doi:10.1371/journal.pone.0061551.
   PubMed Web of Science ®Google Scholar
• Kotoku N, Nakata C, Kawachi T, et al. Synthesis and evaluation of effective photoaffinity probe molecule of furospinosulin-1, a hypoxia-selective growth inhibitor. Bioorg Med Chem. 2014;22:2102–2112. doi:10.1016/j.bmc.2014.02.026.
   PubMed Web of Science ®Google Scholar
• Crump CJ, Am Ende CW, Ballard TE, et al. Development of clickable active site-directed photoaffinity probes for γ-secretase. Bioorg Med Chem Lett. 2012;22:2997–3000. doi:10.1016/j.bmcl.2012.02.027.
   PubMed Web of Science ®Google Scholar
• Liu Y, Patricelli MP, Cravatt BF. Activity-based protein profiling: the serine hydrolases. Proc Natl Acad Sci USA. 1999;96:14694–14699.
   PubMed Web of Science ®Google Scholar
• Speers AE, Cravatt BF. Chemical strategies for activity-based proteomics. Chembiochem. 2004;5:41–47. doi:10.1002/cbic.200300721.
   PubMed Web of Science ®Google Scholar
• Jessani N, Cravatt BF. The development and application of methods for activity-based protein profiling. Curr Opin Chem Biol. 2004;8:54–59. doi:10.1016/j.cbpa.2003.11.004.
   PubMed Web of Science ®Google Scholar
• Jessani N, Liu Y, Humphrey M, et al. Enzyme activity profiles of the secreted and membrane proteome that depict cancer invasiveness. Proc Natl Acad Sci USA. 2002;99:10335–10340. doi:10.1073/pnas.162187599.
   PubMed Web of Science ®Google Scholar
• Jessani N, Humphrey M, McDonald WH, et al. Carcinoma and stromal enzyme activity profiles associated with breast tumor growth in vivo. Proc Natl Acad Sci USA. 2004;101:13756–13761. doi:10.1073/pnas.0404727101.
   PubMed Web of Science ®Google Scholar
• Simon GM, Cravatt BF. Activity-based proteomics of enzyme superfamilies: serine hydrolases as a case study. J Biol Chem. 2010;285:11051–11055. doi:10.1074/jbc.R109.097600.
   PubMed Web of Science ®Google Scholar
• Adam GC, Sorensen EJ, Cravatt BF. Proteomic profiling of mechanistically distinct enzyme classes using a common chemotype. Nat Biotechnol. 2002;20:805–809. doi:10.1038/nbt714.
   PubMed Web of Science ®Google Scholar
• Lapinsky DJ, Johnson DS. Recent developments and applications of clickable photoprobes in medicinal chemistry and chemical biology. Future Med Chem. 2015;7:2143–2171. doi:10.4155/fmc.15.136.
   PubMed Web of Science ®Google Scholar
• Pace CN, McGrath T. Substrate stabilization of lysozyme to thermal and guanidine hydrochloride denaturation. J Biol Chem. 1980;255:3862–3865.
   PubMed Web of Science ®Google Scholar
• Vedadi M, Niesen FH, Allali-Hassani A, et al. Chemical screening methods to identify ligands that promote protein stability, protein crystallization, and structure determination. Proc Natl Acad Sci USA. 2006;103:15835–15840. doi:10.1073/pnas.0605224103.
   PubMed Web of Science ®Google Scholar
• Martinez MD, Jafari R, Ignatushchenko M, et al. Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay. Science. 2013;341:84–87. doi:10.1126/science.1233606.
   PubMed Web of Science ®Google Scholar
• Savitski MM, Reinhard FB, Franken H, et al. Tracking cancer drugs in living cells by thermal profiling of the proteome. Science. 2014;346:1255784. doi:10.1126/science.1255826
   PubMed Web of Science ®Google Scholar
• Huber KV, Olek KM, Müller AC, et al. Proteome-wide drug and metabolite interaction mapping by thermal-stability profiling. Nat Methods. 2015;12:1055–1057. doi:10.1038/nmeth.3590.
   PubMed Web of Science ®Google Scholar
• Franken H, Mathieson T, Childs D, et al. Thermal proteome profiling for unbiased identification of direct and indirect drug targets using multiplexed quantitative mass spectrometry. Nat Protoc. 2015;10:1567–1593. doi:10.1038/nprot.2015.101.
   PubMed Web of Science ®Google Scholar
• Reinhard FB, Eberhard D, Werner T, et al. Thermal proteome profiling monitors ligand interactions with cellular membrane proteins. Nat Methods. 2015;12:1129–1131. doi:10.1038/nmeth.3652.
   PubMed Web of Science ®Google Scholar
• Werner T, Becher I, Sweetman G, et al. High-resolution enabled TMT 8-plexing. Anal Chem. 2012;84:7188–7194. doi:10.1021/ac301553x.
   PubMed Web of Science ®Google Scholar
• Lomenick B, Hao R, Jonai N, et al. Target identification using drug affinity responsive target stability (DARTS). Proc Natl Acad Sci USA. 2009;106:21984–21989. doi:10.1073/pnas.0910040106
   PubMed Web of Science ®Google Scholar
• Robinson TJ, Pai M, Liu JC, et al. High-throughput screen identifies disulfiram as a potential therapeutic for triple-negative breast cancer cells: interaction with IQ motif-containing factors. Cell Cycle. 2013;12:3013–3024. doi:10.4161/cc.26063.
   PubMed Web of Science ®Google Scholar
• Gong F, Peng X, Sang Y, et al. Dichloroacetate induces protective autophagy in LoVo cells: involvement of cathepsin D/thioredoxin-like protein 1 and Akt-mTOR-mediated signaling. Cell Death Dis. 2013;4:e913. doi:10.1038/cddis.2013.438.
   PubMed Web of Science ®Google Scholar
• Derry MM, Somasagara RR, Raina K, et al. Target identification of grape seed extract in colorectal cancer using drug affinity responsive target stability (DARTS) technique: role of endoplasmic reticulum stress response proteins. Curr Cancer Drug Targets. 2014;14:323–336.
   PubMed Web of Science ®Google Scholar
• Chin RM, Fu X, Pai MY, et al. The metabolite α-ketoglutarate extends lifespan by inhibiting ATP synthase and TOR. Nature. 2014;510:397–401. doi:10.1038/nature13264.
   PubMed Web of Science ®Google Scholar
• Lomenick B, Olsen RW, Huang J. Identification of direct protein targets of small molecules. ACS Chem Biol. 2011;6:34–46. doi:10.1021/cb100294v.
   PubMed Web of Science ®Google Scholar
• West GM, Tang L, Fitzgerald MC. Thermodynamic analysis of protein stability and ligand binding using a chemical modification- and mass spectrometry-based strategy. Anal Chem. 2008;80:4175–4185. doi:10.1021/ac702610a.
   PubMed Web of Science ®Google Scholar
• West GM, Tucker CL, Xu T, et al. Quantitative proteomics approach for identifying protein–drug interactions in complex mixtures using protein stability measurements. Proc Natl Acad Sci USA. 2010;107:9078–9082. doi:10.1073/pnas.1000148107
   PubMed Web of Science ®Google Scholar
• Dearmond PD, Xu Y, Strickland EC, et al. Thermodynamic analysis of protein-ligand interactions in complex biological mixtures using a shotgun proteomics approach. J Proteome Res. 2011;10:4948–4958. doi:10.1021/pr200403c.
   PubMed Web of Science ®Google Scholar
• Tran DT, Adhikari J, Fitzgerald MC. Stable isotope labeling with amino acids in cell culture (SILAC)-based strategy for proteome-wide thermodynamic analysis of protein-ligand binding interactions. Mol Cell Proteomics. 2014;13:1800–1813. doi:10.1074/mcp.M113.034702.
   PubMed Web of Science ®Google Scholar
• Bathula C, Tripathi S, Srinivasan R, et al. Synthesis of novel 5-arylidenethiazolidinones with apoptotic properties via a three component reation using piperidine as a bifunctional reagent. Org Biomol Chem. 2016. Just Accepted. doi:10.1039/C6OB01257D.
   PubMedGoogle Scholar
• Unique Polymer Technology (UPT). Shantani. [ cited 2016 Aug 12]. Available from: http://www.shantani.com/UPT.php.
   Google Scholar
• Santanu H, Tripathi S, Dutta PK, et al. Spiro[pyrrolidine-3, 3´-oxindole] as potent anti-breast cancer compounds: their design, synthesis, biological evaluation and cellular target identification. Sci Rep. Forthcoming 2016. Just accepted
   PubMedGoogle Scholar
• Schenone M, Dančík V, Wagner BK, et al. Target identification and mechanism of action in chemical biology and drug discovery. Nat Chem Biol. 2013;9:232–240. doi:10.1038/nchembio.1199.
   PubMed Web of Science ®Google Scholar